Skip to main content
Phase 2 DAHLIA study in SjogrensAnti-neonatal Fc receptor an “nipocalimab” w/remarkably encouraging resultsclinE

Mike Putman EBRheum

1 year 10 months ago

Phase 2 DAHLIA study in Sjogrens Anti-neonatal Fc receptor an “nipocalimab” w/remarkably encouraging results clinESSDAI significantly better at wk24, notably met QOL domains as well Finally getting good news in SjS! #ACR24 @RheumNow #ACRbest Abst#2527 https://t.co/e3uQmqJZ1o

Let me start by confessing something embarrassing: the immune system is just too complex for me to understand. I suspect the onslaught of new drugs with new mechanisms at ACR 2024 may have left many of you feeling similarly. This may be particularly true for the TYK/JAK/STAT signaling pathway, where each agent has a slightly-different combination of binding affinity to various JAK and TYK signaling dimers. In this article I want to share some
📢 Late breaking #2002

➡️In ICI-induced arthritis, patients (n=100) report worsened pain, fatigue, & physical

Caoilfhionn Connolly CaoilfhionnMD

1 year 10 months ago
📢 Late breaking #2002 ➡️In ICI-induced arthritis, patients (n=100) report worsened pain, fatigue, & physical function vs population norms. ➡️High disease activity worsens symptoms #acr24 @RheumNow @jhrheumatology
If a mother has had TNFi during pregnancy, can a baby have a live oral rotavirus vaccine (usually at 2mo)?

This claims

David Liew drdavidliew

1 year 10 months ago
If a mother has had TNFi during pregnancy, can a baby have a live oral rotavirus vaccine (usually at 2mo)? This claims data suggests no increase in diarrhoea Adds to similarly reassuring 🇨🇦prospective cohort data https://t.co/2Tz9zRhPjz Vaccinate away! #ACR24 ABST0806 @RheumNow https://t.co/66OIAR8W6l
We use steroids carefully during pregnancy, and with good reason.

SLR from @eular_org Task Force shows a dose-dependent

David Liew drdavidliew

1 year 10 months ago
We use steroids carefully during pregnancy, and with good reason. SLR from @eular_org Task Force shows a dose-dependent effect of glucocorticoids on preterm birth. (of course, stable autoimmune disease hopefully means avoiding steroids altogether) #ACR24 ABST0810 @RheumNow https://t.co/elWsx5IXtB
📢Late-breaking #2003🔑 Cappelli et al @jhrheumatology finds hip OA is NOT a significant risk factor for #ICI-IA

Caoilfhionn Connolly CaoilfhionnMD

1 year 10 months ago

📢Late-breaking #2003 🔑 Cappelli et al @jhrheumatology finds hip OA is NOT a significant risk factor for #ICI-IA 🔴#ICI-IA linked to lower mortality #ACR24 #ACRBest @RheumNow

Control RA, Build Stronger Bones
Shifting Trends in Initial RA Treatment Approaches

A recent study by Sparks et al (Abstract #0509) reveals evolving tre

Dr. John Cush RheumNow

1 year 10 months ago
Shifting Trends in Initial RA Treatment Approaches A recent study by Sparks et al (Abstract #0509) reveals evolving trends in disease-modifying antirheumatic drug (DMARD) usage for rheumatoid arthritis (RA) over two decades in the U.S. https://t.co/6FN0WayZZR #ACR24 https://t.co/dc3CiNpKmx
Abst#2413 SLE Cohort of > 2900 pts over 50 yrs - Prevalence of proteinuria at the time of SLE dx has not changed over

TheDaoIndex KDAO2011

1 year 10 months ago
Abst#2413 SLE Cohort of > 2900 pts over 50 yrs - Prevalence of proteinuria at the time of SLE dx has not changed over the decades. Prevalence of proteinuria also did not change at 5 and 10 yrs after dx. Earlier use of HCQ has not led to a ⬇️in lupus nephritis. @RheumNow #ACRbest
Nice data from the OTIS Autoimmune Disease in Pregnancy Project re: certolizumab-exposed pregnancies:
- spontaneous loss

David Liew drdavidliew

1 year 10 months ago
Nice data from the OTIS Autoimmune Disease in Pregnancy Project re: certolizumab-exposed pregnancies: - spontaneous loss rate comparable to non-disease controls - no stillbirths - preterm similar to disease controls Plenty positive for CZP in pregnancy! #ACR24 ABST0805 @RheumNow https://t.co/XCRYsioxC0
A study exploring the benefits of treating RA patients to remission after achieving low disease activity (LDA).
Key find

Antoni Chan MD (Prof) synovialjoints

1 year 10 months ago
A study exploring the benefits of treating RA patients to remission after achieving low disease activity (LDA). Key findings: - Among patients initially at LDA, achieving remission (CDAI ≤2.8) led to significantly better functional outcomes and reduced durable medical equipment… https://t.co/SNPKlRieur https://t.co/YIQNMf3Oap
We know most preexisting autoimmune disease is very mangaeable when checkpoint inhibitors are needed.

So great to see t

David Liew drdavidliew

1 year 10 months ago
We know most preexisting autoimmune disease is very mangaeable when checkpoint inhibitors are needed. So great to see that, in the VA, autoimmune disease pts largely haven't missed out on potentially lifesaving cancer immunotherapy. Keep on reassuring! #ACR24 ABST1985 @RheumNow https://t.co/ApOACBLi4K
Abst#1493 complete renal response (< 0.5 g/g w/< 10 mg/day pred); renal remission (UPCR < 0.3 g/g w/< 5 mg/d

TheDaoIndex KDAO2011

1 year 10 months ago

Abst#1493 complete renal response (< 0.5 g/g w/< 10 mg/day pred); renal remission (UPCR < 0.3 g/g w/< 5 mg/day pred). 60 LN pts followed 3 yrs: 40% CRR & 19% RR. Pts not in CRR/RR had⬇️eGFR w/more decline in eGFR over time. No difference b/t CRR/ RR @rheumnow #ACRbest #ACR24

×